22157.jpg
Non-cystic Fibrosis Bronchiectasis Drug Pipeline Market 2024 Featuring Zambon, AstraZeneca, Insmed, NovaBiotics, Haisco Pharmaceutical, Armata Pharmaceuticals, Chiesi Farmaceutici, & CSL Behring
June 14, 2024 06:00 ET | Research and Markets
Dublin, June 14, 2024 (GLOBE NEWSWIRE) -- The "Non-cystic fibrosis bronchiectasis - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Non-cystic...
P&S-Intelligence..jpg
Bronchiectasis Therapeutics Pipeline to Receive More R&D Investments in the Future: P&S Market Research
March 29, 2018 04:28 ET | P&S Market Research
NEW YORK, March 29, 2018 (GLOBE NEWSWIRE) -- According to a new research report titled “Bronchiectasis Therapeutics Pipeline Analysis 2017” published by P&S Market Research, Bronchiectasis...